Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection

Código QR

Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection

The global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection, threatens the entire world. It has affected every aspect of life and increased the burden on both healthcare and socioeconomic systems. Current studies have reve...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hi Eun Jung, Heung Kyu Lee
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	SARS-CoV-2 COVID-19 Toll-like receptor (TLR) cytokine storm hyperinflammation Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/ba4262cae7134e4689dc32de7dd8091b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Toll-like Receptors are Key Participants in Innate Immune Responses
por: ARANCIBIA,SERGIO A, et al.
Publicado: (2007)

The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus Challenge
por: Patrick Younan, et al.
Publicado: (2017)

A pathogen-like antigen-based vaccine confers immune protection against SARS-CoV-2 in non-human primates
por: Chang Guo, et al.
Publicado: (2021)

A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels
por: Denis A. Kleymenov, et al.
Publicado: (2021)

Aeromonas hydrophila infection induces Toll-like receptor 2 (tlr2) and associated downstream signaling in Indian catfish, Clarias magur (Hamilton, 1822)
por: Chinmayee Muduli, et al.
Publicado: (2021)

THE ROLE OF INNATE IMMUNITY FACTORS IN TUMORIGENESIS PROCESS
por: O. A. Svitich, et al.
Publicado: (2018)

THE TOLL-LIKE RECEPTORS ROLE IN INFLAMMATORY DISEASES OF THE BRONCHOPULMONARY SYSTEM PATHOGENESIS
por: E. S. Korovkina, et al.
Publicado: (2016)

ASSOCIATION OF TLR2, TLR4, TLR9 GENE EXPRESSION RELATED TO INNATE IMMUNITY WITH IN VIVO ACUTE RESPIRATORY INFECTIONS CAUSED BY KLEBSIELLA PNEUMONIAE
por: E. V. Budanova, et al.
Publicado: (2018)

Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
por: Kavya Srinivasan, et al.
Publicado: (2021)

Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm
por: Wiktoria Feret, et al.
Publicado: (2021)

An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants
por: Mohammad Enamul Hoque Kayesh, et al.
Publicado: (2021)

Coronavirus Disease 2019: Clinics, Treatment, and Prevention
por: Francesco Robert Burkert, et al.
Publicado: (2021)

Interrelation between the system of complement, Tolllike receptors, CD antigens and cytokines in normal and pathological condition. Review
por: M. V. Lakhtin, et al.
Publicado: (2015)

Respiratory epithelium: Place of entry and / or defense against SARS-CoV-2 virus
por: Leštarević Snežana, et al.
Publicado: (2021)

Hyperexpression of TLR2 and TLR4 in patients with ischemic stroke in acute period of the disease
por: L. V. Gankovskaya, et al.
Publicado: (2020)

CLINICAL SIGNIFICANCE OF Toll2, Toll4, CD14, AND HLA-DR EXPRESSION ON THE MONOCYTES IN PATIENTS WITH SEPSIS
por: V. A. Lazanovich, et al.
Publicado: (2015)

SARS‐CoV‐2 neutralizing antibodies decline over one year and patients with severe COVID‐19 pneumonia display a unique cytokine profile
por: Vimvara Vacharathit, et al.
Publicado: (2021)

SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody
por: Collin Jugler, et al.
Publicado: (2021)

Impaired Innate Immunity in Pediatric Patients Type 1 Diabetes—Focus on Toll-like Receptors Expression
por: Katarzyna Kurianowicz, et al.
Publicado: (2021)

Toll-Like Receptor 4: A Macrophage Cell Surface Receptor Is Activated by Trimethylamine-N-Oxide
por: Mohammad Saeed Hakhamaneshi, et al.
Publicado: (2021)

Total Lipopolysaccharide from the Human Gut Microbiome Silences Toll-Like Receptor Signaling
por: Eva d’Hennezel, et al.
Publicado: (2017)

Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
por: Hayder M. Al-kuraishy, et al.
Publicado: (2021)

The evolution of the metazoan Toll receptor family and its expression during protostome development
por: Andrea Orús-Alcalde, et al.
Publicado: (2021)

The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19
por: George El-Arif, et al.
Publicado: (2021)

Ventricular TLR4 Levels Abrogate TLR2-Mediated Adverse Cardiac Remodeling upon Pressure Overload in Mice
por: Elise L. Kessler, et al.
Publicado: (2021)

Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK
por: Jackline Joy Martín Lasola, et al.
Publicado: (2021)

Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
por: Jamal Majidpoor, et al.
Publicado: (2022)

Efecto del ejercicio agudo sobre la expresión del receptor tipo Toll-4 y los mecanismos inflamatorios en corazón de rata
por: Cristi-Montero,Carlos, et al.
Publicado: (2012)

EXPRESSION FEATURES OF TOLL-LIKE RECEPTOR 2 AND TOLL-LIKE RECEPTOR 4 IN CHILDREN WITH ASTHMA
por: L. V. Gankovskaya, et al.
Publicado: (2017)

Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll‐like receptors 7 and 8
por: Andreas Port, et al.
Publicado: (2021)

Cytokine Response in SARS-CoV-2 Infection in the Elderly
por: Sherwani S, et al.
Publicado: (2020)

The role of toll-like receptors in peptic ulcer disease
por: Shizhu Jin, et al.
Publicado: (2021)

GENOMIC FACTORS (TOLL-LIKE RECEPTORS GENES) IN DEVELOPMENT OF ATHEROSCLEROSIS AND ITS CLINICAL MANIFESTATIONS
por: I. I. Zhidkova, et al.
Publicado: (2017)

Anti-viral and pro-inflammatory functions of Toll-like receptors during gamma-herpesvirus infections
por: Marta Maria Gaglia
Publicado: (2021)

Expression of Toll-like receptors in emotiogenic structures of rat brain is changed under longterm alcohol consumption and ethanol withdrawal
por: M. I. Airapetov, et al.
Publicado: (2020)

Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19
por: Helena Codina, et al.
Publicado: (2021)

Streptococcus pneumoniae PepO promotes host anti-infection defense via autophagy in a Toll-like receptor 2/4 dependent manner
por: Zhaoche Shu, et al.
Publicado: (2020)

Gene profiling of Toll-like receptor signalling pathways in neutrophils of patients with acute-on-chronic liver failure
por: Yi Zhang, et al.
Publicado: (2021)

Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19
por: Yingjie Wu, et al.
Publicado: (2020)

Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
por: Ravi Kant, et al.
Publicado: (2021)